New Hampshire is latest state to sue CT based OxyContin manufacturer 

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

CONCORD, N.H.– The New Hampshire attorney general’s office is suing Purdue Pharma, alleging that the drug manufacturer has continued its deceptive marketing of OxyContin in a state that has been called the “ground zero” of the opioid epidemic.

In a civil complaint filed Tuesday, the state alleges that Purdue Pharma, based in Stamford, has downplayed oxycodone’s risk of addiction, overstated its effectiveness, claimed it is nearly impossible to abuse and failed to report suspicious prescribers.

A spokesman for Cranbury, New Jersey-based Purdue Pharma the company vigorously denies the allegations, though it shares New Hampshire’s concerns about the opioid crisis and is committed to finding solutions.

It’s the latest in a string of lawsuits by state, county and local governments accusing prescription opioid manufacturers of fraud and deceptive marketing.